Dr. Monica Bertagnolli grew up on a cattle ranch in southwestern Wyoming. The work was physical, practical, and nonnegotiable. Animals needed care. Equipment broke. Weather dictated terms. Long before she led some of the most important scientific institutions in the world, she learned to think in terms of responsibility, consequences, and real outcomes.
She studied biochemical engineering at Princeton, earned her medical degree at the University of Utah, and trained as a surgeon at Brigham and Women’s Hospital in Boston. But unlike many leaders who gradually drift away from clinical medicine, Monica remained anchored to patient care throughout her career.
Her field was surgical oncology. Cancer, for a surgeon, is concrete. Not a research abstraction or intellectual puzzle. It is a patient sitting across from you, trying to absorb life changing news. It is uncertainty, judgment, difficult tradeoffs, and science tested against the stubborn realities of human life.
Monica built a distinguished career treating gastrointestinal cancers and sarcomas while studying the molecular machinery of disease. Over time, her work expanded beyond the operating room into the larger architecture of medicine itself. She led the Alliance for Clinical Trials in Oncology, one of the world’s largest cancer research networks, overseeing studies involving thousands of patients and institutions. Her work advanced more rigorous clinical data systems, broader participation in trials, and a sharper, more individualized understanding of how cancer should be studied and treated.
In 2022, she became Director of the National Cancer Institute. A year later, she was appointed Director of the National Institutes of Health, becoming the first surgeon to lead the agency. These are rarefied roles, but titles alone miss something essential about Monica. She still speaks with the perspective of a physician who has spent years helping patients navigate frightening diagnoses and impossible decisions. The human stakes remain close at hand.
Now, as the incoming President of the National Academy of Medicine, she steps into a role at the center of medicine, science, public health, and policy. It fits naturally. She understands molecular biology and clinical judgment, research infrastructure and healthcare delivery, national leadership and the deeply personal realities of illness. There is also a grounded practicality about her that feels connected to where she began. A belief that science matters not because it is elegant, influential, or technologically impressive, but because it can improve the lives of real people.
